Charles River Laboratories | CRL - Net Income


Charles River Laboratories reported $-276.56M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 305M 129M Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Bruker USD 26M 88.4M Dec/2025
Cardinal Health USD 467M 17M Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Cigna USD 1.23B 55.22B Dec/2025
Concord Medical Services Hldg CNY -90.98M 284.02M Jun/2023
CVS Health USD 2.94B 6.92B Dec/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -146M 281M Dec/2025
Elevance Health USD 547M 642M Dec/2025
Galapagos EUR -202.11M 96.36M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Humana USD -796M 991M Dec/2025
Illumina USD 334M 184M Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Lonza CHF 307M 22M Dec/2024
McKesson USD 1.19B 76M Dec/2025
Merck EUR 902M 250M Sep/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Novartis USD 3.93B 96M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Quest Diagnostics USD 245M 0 Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
United Therapeutics USD 364.3M 25.6M Dec/2025
UnitedHealth USD 10M 2.34B Dec/2025
Veradigm USD 14.53M 78.55M Sep/2022
Waters USD 225.21M 76.29M Dec/2025
West Pharmaceutical Services USD 132.1M 7.9M Dec/2025